Cancer Genomics Consortium (CGC) is a 501(c)3 non-profit organization whose mission is to providing high quality education and promoting best practices in clinical cancer genomics. Our vision is that all cancer patients will be accurately diagnosed for their underlying genomic alterations to help them receive the most appropriate therapy. CGC will be the authoritative organization for guidance on the best practice of clinical cancer genomic testing.
CANCER GENOMICS CONSORTIUM的外部链接
2955Ridgelake Dr
US，Louisiana，Metairie，70002
Correct answer:? Indicates hyperdiploidy Explanation of answer:? When multiple probes demonstrate copy gains, the most likely answer is a hyperdiploid karyotype; however, it is important to demonstrate this subtype by either multiple centromere probes (FISH) or by karyotype.?
此处无法显示此内容
在领英 APP 中访问此内容等
Join us in congratulating Lisa Lansdon, PhD, FACMG who is being featured in our November #CGCspotlight! Lisa is a member of the Education Committee and is the leader of the Macrogenomic Event Detection in Solid Tumors Working Group. Fun fact about Lisa: Lisa enjoys running and is an ultimate frisbee and cross-country ski enthusiast. When she isn’t outdoors, you can find her testing new recipes in the kitchen or spending time with her family.
The mission of the Genomic Resources Development Committee (GRDC) is to support the development, implementation, and maintenance of genomic resources and promote access to resources. The GRDC has been working hard to bring you the Geneticist Toolkit this past year, providing practice resources for laboratory geneticists including links to online resources and publications, helpful tip sheets describing how and when to use some of these resources, as well as introductory presentations on a variety of topics. https://lnkd.in/gvbS7xn5